These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

266 related items for PubMed ID: 21450755

  • 1. GnRH agonist for triggering of final oocyte maturation: time for a change of practice?
    Humaidan P, Kol S, Papanikolaou EG, Copenhagen GnRH Agonist Triggering Workshop Group.
    Hum Reprod Update; 2011; 17(4):510-24. PubMed ID: 21450755
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Consistent high clinical pregnancy rates and low ovarian hyperstimulation syndrome rates in high-risk patients after GnRH agonist triggering and modified luteal support: a retrospective multicentre study.
    Iliodromiti S, Blockeel C, Tremellen KP, Fleming R, Tournaye H, Humaidan P, Nelson SM.
    Hum Reprod; 2013 Sep; 28(9):2529-36. PubMed ID: 23873146
    [Abstract] [Full Text] [Related]

  • 5. The luteal phase after GnRH-agonist triggering of ovulation: present and future perspectives.
    Humaidan P, Papanikolaou EG, Kyrou D, Alsbjerg B, Polyzos NP, Devroey P, Fatemi HM.
    Reprod Biomed Online; 2012 Feb; 24(2):134-41. PubMed ID: 22197130
    [Abstract] [Full Text] [Related]

  • 6. GnRHa trigger and individualized luteal phase hCG support according to ovarian response to stimulation: two prospective randomized controlled multi-centre studies in IVF patients.
    Humaidan P, Polyzos NP, Alsbjerg B, Erb K, Mikkelsen AL, Elbaek HO, Papanikolaou EG, Andersen CY.
    Hum Reprod; 2013 Sep; 28(9):2511-21. PubMed ID: 23753114
    [Abstract] [Full Text] [Related]

  • 7. Endometrial gene expression in the early luteal phase is impacted by mode of triggering final oocyte maturation in recFSH stimulated and GnRH antagonist co-treated IVF cycles.
    Humaidan P, Van Vaerenbergh I, Bourgain C, Alsbjerg B, Blockeel C, Schuit F, Van Lommel L, Devroey P, Fatemi H.
    Hum Reprod; 2012 Nov; 27(11):3259-72. PubMed ID: 22930004
    [Abstract] [Full Text] [Related]

  • 8. Ovarian hyperstimulation syndrome prevention by gonadotropin-releasing hormone agonist triggering of final oocyte maturation in a gonadotropin-releasing hormone antagonist protocol in combination with a "freeze-all" strategy: a prospective multicentric study.
    Griesinger G, Schultz L, Bauer T, Broessner A, Frambach T, Kissler S.
    Fertil Steril; 2011 May; 95(6):2029-33, 2033.e1. PubMed ID: 21371705
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Dual trigger of oocyte maturation with gonadotropin-releasing hormone agonist and low-dose human chorionic gonadotropin to optimize live birth rates in high responders.
    Griffin D, Benadiva C, Kummer N, Budinetz T, Nulsen J, Engmann L.
    Fertil Steril; 2012 Jun; 97(6):1316-20. PubMed ID: 22480822
    [Abstract] [Full Text] [Related]

  • 11. GnRH agonist for triggering final oocyte maturation in the GnRH antagonist ovarian hyperstimulation protocol: a systematic review and meta-analysis.
    Griesinger G, Diedrich K, Devroey P, Kolibianakis EM.
    Hum Reprod Update; 2006 Jun; 12(2):159-68. PubMed ID: 16254001
    [Abstract] [Full Text] [Related]

  • 12. GnRH Agonist Trigger and LH Activity Luteal Phase Support versus hCG Trigger and Conventional Luteal Phase Support in Fresh Embryo Transfer IVF/ICSI Cycles-A Systematic PRISMA Review and Meta-analysis.
    Haahr T, Roque M, Esteves SC, Humaidan P.
    Front Endocrinol (Lausanne); 2017 Jun; 8():116. PubMed ID: 28638367
    [Abstract] [Full Text] [Related]

  • 13. Elective cryopreservation of all pronuclear oocytes after GnRH agonist triggering of final oocyte maturation in patients at risk of developing OHSS: a prospective, observational proof-of-concept study.
    Griesinger G, von Otte S, Schroer A, Ludwig AK, Diedrich K, Al-Hasani S, Schultze-Mosgau A.
    Hum Reprod; 2007 May; 22(5):1348-52. PubMed ID: 17303632
    [Abstract] [Full Text] [Related]

  • 14. Oocyte maturation employing a GnRH agonist in combination with low-dose hCG luteal rescue minimizes the severity of ovarian hyperstimulation syndrome while maintaining excellent pregnancy rates.
    Radesic B, Tremellen K.
    Hum Reprod; 2011 Dec; 26(12):3437-42. PubMed ID: 21997895
    [Abstract] [Full Text] [Related]

  • 15. Cycles triggered with GnRH agonist: exploring low-dose HCG for luteal support.
    Castillo JC, Dolz M, Bienvenido E, Abad L, Casañ EM, Bonilla-Musoles F.
    Reprod Biomed Online; 2010 Feb; 20(2):175-81. PubMed ID: 20113955
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Ovarian hyperstimulation syndrome prevention strategies: Luteal support strategies to optimize pregnancy success in cycles with gonadotropin-releasing hormone agonist ovulatory trigger.
    Engmann L, Benadiva C.
    Semin Reprod Med; 2010 Nov; 28(6):506-12. PubMed ID: 21082510
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.